Page last updated: 2024-08-25

ropivacaine and Granulocytic Leukemia, Chronic

ropivacaine has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Peng, X; Yu, H; Zheng, Q	1

Other Studies

1 other study(ies) available for ropivacaine and Granulocytic Leukemia, Chronic

Article	Year
Local Anesthetic Drug Inhibits Growth and Survival in Chronic Myeloid Leukemia Through Suppressing PI3K/Akt/mTOR. The American journal of the medical sciences, 2018, Volume: 355, Issue:3 Topics: Amides; Anesthetics, Local; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dasatinib; G2 Phase Cell Cycle Checkpoints; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Ropivacaine; Signal Transduction; Stem Cells; TOR Serine-Threonine Kinases	2018

Article

Year

Local Anesthetic Drug Inhibits Growth and Survival in Chronic Myeloid Leukemia Through Suppressing PI3K/Akt/mTOR.

The American journal of the medical sciences, 2018, Volume: 355, Issue:3

Topics: Amides; Anesthetics, Local; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dasatinib; G2 Phase Cell Cycle Checkpoints; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Ropivacaine; Signal Transduction; Stem Cells; TOR Serine-Threonine Kinases

2018